These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 19200816)

  • 1. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain).
    Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA;
    Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of the meningococcal disease in Catalonia before and after vaccination against serogroup C].
    Martínez AI; Domínguez A; Oviedo M; Minguell S; Jansà JM; Codina G; Vázquez JA;
    Rev Esp Salud Publica; 2009; 83(5):725-35. PubMed ID: 20111820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing epidemiology of meningococcal disease in the United States, 1992-1996.
    Rosenstein NE; Perkins BA; Stephens DS; Lefkowitz L; Cartter ML; Danila R; Cieslak P; Shutt KA; Popovic T; Schuchat A; Harrison LH; Reingold AL
    J Infect Dis; 1999 Dec; 180(6):1894-901. PubMed ID: 10558946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
    Krízová P; Musílek M; Kalmusová J
    Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meningococcal disease in Spain, 1990-1997. Change in its epidemiological pattern].
    de Mateo Ontañón S
    Rev Esp Salud Publica; 2000; 74(4):387-96. PubMed ID: 11031848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination].
    Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R
    Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual report of the Australian Meningococcal Surveillance Programme, 1997.
    Commun Dis Intell; 1998 Oct; 22(10):205-11. PubMed ID: 9803595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual report of the Australian Meningococcal Surveillance Programme, 1999.
    Commun Dis Intell; 2000 Jul; 24(7):181-9. PubMed ID: 10981347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serogroup B meningococcal disease--Oregon, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Feb; 44(7):121-4. PubMed ID: 7845348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual report of the Australian Meningococcal Surveillance Programme, 1998. The Australian Meningococcal Surveillance Programme.
    Commun Dis Intell; 1999 Nov; 23(12):317-23. PubMed ID: 10615794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meningococcal infection caused by Neisseria meningitidis serogroup C].
    Ursua MI; Rodríguez-Mayo M; Fernández-Quintairos J; Domínguez D; Luaces J; Agulla A
    Enferm Infecc Microbiol Clin; 1997; 15(7):369-72. PubMed ID: 9410050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of meningococcal serogroup C conjugate vaccine in Scotland.
    Mooney JD; Christie P; Robertson C; Clarke SC
    Clin Infect Dis; 2004 Aug; 39(3):349-56. PubMed ID: 15307001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of invasive meningococcal infections of children in Slovenia during 1993-1999.
    Paragi M; Kraigher A; Cizman M; Gubina M; Caugant DA
    Cent Eur J Public Health; 2001 May; 9(2):79-82. PubMed ID: 11503279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global epidemiology of meningococcal disease.
    Harrison LH; Trotter CL; Ramsay ME
    Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual report of the Australian Meningococcal Surveillance Programme, 2000.
    Commun Dis Intell Q Rep; 2001 Aug; 25(3):113-21. PubMed ID: 11596711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.